© Christin Stottmeier, MDC
BIMSB News
April 2025
- The decrypter of cryptic proteins
- How do disordered proteins drive neurological diseases? Dr. Melissa Birol uses advanced imaging and brain organoids to uncover the hidden functions of these mysterious proteins. She hopes to find novel ways to treat incurable diseases such as Alzheimer’s and Parkinson’s.
- Towards understanding tumors in 3D
- Researchers in Nikolaus Rajewsky’s lab at Max Delbrück Center combined high-resolution, single-cell spatial technologies to map a tumor’s cellular neighborhoods in 3D and identify potential targets for personalized cancer therapy. They describe their findings in two separate papers in “Cell Systems.”
- Sibylle Bergemann photo exhibition
- Since April 3, MDC-BIMSB in Berlin Mitte has been hosting an exhibition of 40 photographs by iconic photographer Sibylle Bergemann. During the opening, which was attended by her daughter Frieda and granddaughter Lily von Wild, the rooftop terrace was named in Bergemann’s honor.
- How our cells learn to defeat cancer: A podcast with Markus Landthaler
- mRNA research has delivered vaccines against the coronavirus. Could RNA technology one day even defeat cancer? Markus Landthaler is working on deciphering the mode of action of RNA-binding proteins and making them usable.
March 2025
- AI and science unite at first HFMI workshop
- How can AI transform scientific research? The Helmholtz Foundation Model Initiative brought together a diverse group of experts during its first workshop. In an interview, Max Delbrück Center scientist Dagmar Kainmüller explains foundation models and why interdisciplinary collaboration is important.
- Inflammatory messenger fuels Alzheimer’s
- Researchers from Charité – Universitätsmedizin Berlin and the Max Delbrück Center have detailed the precise mechanism through which the inflammatory signaling molecule IL-12 contributes to Alzheimer’s disease. The study was published in in the journal “Nature Aging.”
February 2025
- The juggler of numbers
- Jakob Metzger has developed a new generation of brain organoids that are easier to mass-produce and uniform. The data they provide on rare neurological diseases can speed up the time it takes to find new therapies.
- Professorship awarded to Jan Philipp Junker
- Jan Philipp Junker’s new full professorship at Charité Universitätsmedizin Berlin will enable him to push the boundaries of tissue regeneration research. Using single-cell sequencing, microscopy and genetics, he hopes to unlock ways to enhance organ regeneration in mammals.
- Access to high-performance computing for businesses
- Helmholtz invests €18 million in AI innovation ecosystems: Nine Helmholtz centers open their High-Performance Computing infrastructure to companies and connect businesses with their AI experts. More than €2 million will go to the Max Delbrück Center.
- When blood cancer starts to spread
- When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers from Berlin and Heidelberg report in “Science Immunology.” The detailed insights into cancer progression could advance diagnostics and treatment.
January 2025
- “Seize the chance – it’s worth it!”
- Doctoral student Philipp Roth went to New York as part of the Max Delbrück Center Exchange Program in Medical Systems Biology. In this interview, he discusses his research collaboration with a lab at NYU and how the exchange benefitted him in ways he could not have imagined.
December 2024
- Images of transformation
- In her exhibition “Metamorphosis,” Eleonora Adami showcases digital illustrations and cyanotype prints. These works, which invite viewers to reflect on the concepts of change and transformation, will be on display at MDC-BIMSB until the end of January.
- Leibniz Prize awarded to Ana Pombo
- The German Research Foundation (DFG) has announced that biochemist Ana Pombo from the Max Delbrück Center is among this year’s winners of the Gottfried Wilhelm Leibniz Prize. With a grant of €2.5 million, the Leibniz Prize is one of the highest endowed research prizes in Germany.
- Driving conversations on diversity
- During the second annual Diversity Week, our community took part in a series of events. They ranged from simulating the environments of disabled people, to discussing the importance of a diverse workplace. The aim was to raise awareness and to foster a welcoming work environment for everyone.
November 2024
- BBAW Prize for cancer researcher Simon Haas
- Simon Haas has been awarded the Berlin-Brandenburg Academy of Sciences and Humanities (BBAW) Prize for the promotion of cancer research, sponsored by the Monika Kutzner Foundation. His outstanding research focuses on the causes and the development of new concepts for the treatment of blood cancer.
- Meeting the next generation of physician-scientists
- The Emerald program is shaping a new wave of physician-scientists by bridging clinical practice and biomedical research. Recently, fellows from all across Europe met in Berlin. We interviewed the organizers about the highlights and the community’s plans to improve healthcare.
- Global influencers of science
- Three researchers at Max Delbrück Center – Sofia Forslund, Friedemann Paul, and Nikolaus Rajewsky – are among the most Highly Cited Researchers in the world in 2024, making the list two years in a row. Germany ranks fourth of countries and regions, behind the U.S., mainland China and the U.K.
October 2024
- Beyond ChatGPT: Foundation models for research
- Foundation models are complex AI applications with enormous potential. Trained on vast datasets from medicine, climate, or material science, they can uncover new relationships and make predictions. Helmholtz is supporting this pioneering work, with €5.55 million going to the Max Delbrück Center.
- Cancer risk linked to p53 in Ulcerative Colitis
- Researchers in the lab of Michael Sigal at the Max Delbrück Center and Charité – Universitätsmedizin Berlin have elucidated the role of the p53 gene in ulcerative colitis. The study, published in “Science Advances,” suggests a potential new drug target to stop disease progression to cancer.
- A dialogue between science and art
- From November 1 to 10, 2024, researchers and science enthusiasts will come together during Berlin Science Week to discuss important questions about science and society. Kicking off the week, the Max Delbrück Center will present its photo exhibition “Discoverers” for the first time.
- Navigating cancer treatment with the help of AI
- Cancer treatment has become complex. An AI based online tool developed by researchers at the Max Delbrück Center can already help oncologists and cancer patients find the most up to date personalized treatment.
September 2024
- The pioneer of single-cell sequencing
- Ashley Sanders, Group Leader of the Genome Instability and Somatic Mosaicism Lab, developed a technique to sequence strands of DNA in single cells. Today it is the most accurate method to detect DNA rearrangements. She hopes the technique will help reveal clues on how diseases develop.
- Berlin Science Week
- From November 1 to 10, 2024, researchers and science enthusiasts will once again gather in Berlin to discuss current developments and challenges in science, business and society - with each other and with the public. The Max Delbrück Center will once again be contributing exciting events this year, online and on site. Join us!
August 2024
- Embracing failure in art and science
- We can learn from failure, yet often we hide our setbacks, especially in our professional lives. At the next SPARK event on September 5, enjoy a piano and violin concert followed by an invigorating discussion between musicians and scientists as they explore the concept of “A CV of failures.”
- A new culprit in Huntington’s disease
- Researchers in Berlin and Düsseldorf have implicated a new gene in the progression of Huntington’s disease in a brain organoid model. The gene may contribute to brain abnormalities much earlier than previously thought. The study was published in “Nature Communications.”
July 2024
- A vast viral world in wastewater
- Deep metagenomic sequencing of wastewater in Berlin over 17 months shows this technique could help forecast disease outbreaks and monitor the spread of human pathogens. It can also reveal thousands of novel viruses, according to a study by the Landthaler lab published in “Environment International.”
- NIMSB’s first visit to the Max Delbrück Center
- The Max Delbrück Center welcomed a delegation from the Lisbon based NOVA Institute for Medical Systems Biology (NIMSB) for the first time to Berlin. The aim: to solidify the connection between the two institutes and to create a lasting platform for exchanging ideas and expertise.
- Career wisdom and alumni connections
- This year’s Alumni Day saw former employees return to the Max Delbrück Center to reunite with colleagues, forge new connections and support the development of others.
- Congratulations, PhD class of 2024!
- The Max Delbrück Center hosted a graduation ceremony to honor 20 young researchers who have successfully defended their PhD theses this year. They were awarded their diplomas in front of proud colleagues, friends and family.
- Simon Haas awarded ERC Proof of Concept Grant
- Simon Haas receives a Proof-of-Concept Grant from the European Research Council in the amount of €150,000. Immunotherapies use the immune system to fight against cancer. Haas' team from the joint single-cell focus of Max Delbrück Center, BIH, and Charité is developing methods to predict the efficacy of immunotherapies.
- New center of excellence for single cell omics
- On July 8, the Max Delbrück Center and Bruker will kick off a strategic partnership to build a first-of-its-kind innovation hub for systems medicine. The new center will focus on the development and application of mass spectrometry based single-cell and multi-omics technologies.
June 2024
- 3D maps of diseased tissues at subcellular precision
- An open-source platform developed by researchers in Nikolaus Rajewsky’s lab at the Max Delbrück Center creates molecular maps from patient tissue samples with subcellular precision, enabling detailed study and potentially enhancing routine clinical pathology. The study was published in “Cell.”
- This was the Long Night 2024 at the Max Delbrück Center
- The night of June 22, 2024 was a night of discoveries: Our visitors had the opportunity to dive into the world of biomedical research. They not only had the chance to look over the shoulders of our scientists at work and experiment for themselves, but also to experience the interplay between art and science. Here are some of the highlights of the evening.
- AI’s adventures in genomics
- This year’s Berlin Institute of Systems Biology of the Max Delbrück Center summer meeting explored “AI’s Adventures in Genomics.” The meeting provided molecular and computational biologists a forum to discuss the latest advances, challenges, and prospects in harnessing AI for biomedical research.
- In severe COVID-19, neutrophils work overtime
- Whether COVID-19 is mild or severe depends not only on how aggressive the coronavirus is, but also on the immune response of the infected individual. Using single-cell analyses, Berlin researchers have now identified two distinct molecular patterns that are typical, they write in “Cell Reports.”
- Delve into the heart of research
- Whether it's a pub quiz, enjoying art, a lab tour or a hands-on experiment – during the Long Night of Science on June 22, visitors in Berlin-Buch and Mitte can explore biomedical research at the Max Delbrück Center from many different perspectives. A look deep into the human heart is also on offer.
- Mentoring: a boost for your career
- Without great scientists, there is no great research. For this reason, the Max Delbrück Center supports young researchers and science managers through various mentoring programs – both internally and externally. In this installment of “We at MDC,” mentees and mentors talk about their experiences.
May 2024
- Genetic mosaicism more common than thought
- Blood stem cells from healthy people carry major chromosomal alterations, a study in “Nature Genetics” by researchers at the Max Delbrück Center and the European Molecular Biology Laboratory finds. The discovery suggests that we are all genetic mosaics, which may contribute to ageing-related diseases.
April 2024
- No research without IT girls
- Life sciences research generates enourmous amounts of data; their analysis is thus no longer possible without machine learning or artificial intelligence. On Girls' Day, students from grades 6 to 12 found out what female mathematicians and computer scientists do at the Max Delbrück Center.
March 2024
- Awards for the best PhDs and Postdocs of 2023
- Their research is outstanding, and they’re also committed to the Max Delbrück Center and engaged in our community — Manqiang Lin and Artsemi Yushkevich wrote the best papers in 2023; Hendrik Bartolomaeus, Eleonore Adami and Ulrike Löber received the Postdoc Awards for 2023.
- Simon Haas receives Heisenberg professorship
- The German Research Foundation (DFG) will fund single-cell scientist Simon Haas in its Heisenberg program. Therefore, the Berlin Institute of Health at Charité (BIH) is establishing a Heisenberg professorship in systems hematology. After five years, the BIH will make the professorship permanent.
- From Berlin to Lisbon and back
- NOVA University and Max Delbrück Center are jointly establishing the NOVA Institute for Medical Systems Biology (NIMSB). Both institutions have developed a shared vision to push the boundaries of precision medicine. “Insights” spoke to the three project leads in Lisbon and Berlin.
February 2024
- Our everyday heroes
- In addition to their work at the Max Delbrück Center, many people from research and administration volunteer their time. For "We at the MDC," six everyday heroes tell us how they help others and strengthen the community in their free time.
- A small gesture for us, a great joy for others
- During three campaigns in December 2023, employees of the Max Delbrück Center took the opportunity to donate to good causes. This resulted in more than 300 gifts for children and more than 1,400 euros for the 'Kältebus' (cold bus) for homeless people in Berlin. We spoke with the organizers.
- Celebrating women in STEM
- Seven women, seven careers – one conclusion: women and girls who are passionate about science should just go for it and not let anyone stop them. Because if you keep going, no obstacle will be insurmountable.
January 2024
- Preventing the mass die-off of neurons
- Melissa Birol of the Max Delbrück Center is looking to understand early stages of Alzheimer’s disease. Her focus is on the interplay between the lipid metabolism of nerve cells and the spread of tau protein. The Alzheimer Research Initiative is funding her work with 193,500 euros.
- Senator for Research visits Max Delbrück Centre
- Big data, the opportunities of precision medicine, recent advances in organoid technology, and new developments in proteomics: Berlin's Senator for Higher Education and Research, Health and Long-Term Care, Ina Czyborra, visited the Max Delbrück Center in early January to learn about the latest developments in biomedicine.
December 2023
- "I gained self-confidence in New York"
- Working in Berlin-Mitte and New York for your PhD – Lena Nitsch conducts research at both the MDC-BIMSB and New York University. For “We at the MDC”, the doctoral student discusses how it is to work in two labs, her experiences in the United States, and what she has learned through the “MDC-NYU PhD Exchange Program”.
- Leif Ludwig is named EMBO Young Investigator
- The European Molecular Biology Organization has selected Leif. S. Ludwig from the Berlin Institute of Health at Charité (BIH) and the Max Delbrück Center to become an EMBO Young Investigator. The program provides support to outstanding young life scientists.
November 2023
- No precision medicine without diversity
- Biomedical research is mostly geared towards white men. During the Berlin Science Week, researchers discussed how this can be changed and how questions of diversity can be better taken into account in laboratories. Didn't have time to join? We have documented the event for you as a video.
- From Barcelona to Berlin
- To attract renowned researchers to Berlin, Stiftung Charité is funding “Visiting Fellows” with 1.5 million euros. One of them is Manuel Irimia from Barcelona. He is coming to the Max Delbrück Center for three years to analyze gene regulation.
- A new hub for cutting-edge cancer care
- From 2024, the Federal Government and the State of Berlin will fund the establishment of the National Center for Tumor Diseases (NCT) Berlin. The new site is a cooperation between DKFZ and Charité, BIH, and Max Delbrück Center aimed at closely integrating clinical and translational cancer research.
- Lisec-Artz Prize goes to Simon Haas
- Simon Haas has been awarded the Lisec-Artz Prize, endowed with €10,000, for his single-cell analysis of communication between stem and immune cells in blood cancer. The University of Bonn Foundation established this prize to honor outstanding early-career cancer researchers.
- Influential in their field
- Sofia Forslund, Friedemann Paul, and Nikolaus Rajewsky are among the Highly Cited Researchers 2023. Each year the company Clarivate compiles a "Who's Who" list of highly influential researchers.
- DEI Week kicks off at the Max Delbrück Centre
- The Max Delbrück Center will host its first-ever Diversity, Equity, and Inclusion Week, from November 13 to 17, 2023. The event will foster engagement, support, and unity of its research community, and will feature workshops, panel discussions, and community activities at its Buch and Mitte locations.
October 2023
- Controlling Organoids with light
- Organoids help researchers understand biological processes in health and in disease. It is, however, difficult to influence the way in which they organize themselves into complex tissues. Now a group led by Nikolaus Rajewsky has found a new way to do so. They report their work in Nature Methods.
- Why research needs diversity
- A data gap that threatens timely diagnosis and treatment for half the population, the visibility of female researchers in Wikipedia, and myriads of microbes in and on our bodies – the Max Delbrück Center's program for the Berlin Science Week 2023 is focused on dimensions of diversity.
Sep 2023
- Following cells on their path to development
- It borders on the miraculous how an entire animal emerges from a single egg cell. In order to understand the underlying molecular mechanisms, Markus Mittnenzweig is establishing the Computational and Developmental Biology Lab at the Max Delbrück Center.
- The Max Delbrück Center celebrates 15 years of MDC‑BIMSB
- Internationally renowned for pioneering achievements and geared to inter-institutional cooperation: 22 research groups at the Berlin Institute for Medical Systems Biology in the Max Delbrück Center (MDC-BIMSB) explore how genes regulate life. It is now celebrating its 15th birthday.
Aug 2023
- Preparations for new Einstein Center begin
- With a grant of 600,000 euros, the Einstein Foundation Berlin is funding the preliminary module for an Einstein Center for Early Disease Interception. Ten Berlin institutions – including the Max Delbrück Center – are looking to develop, integrate and apply the technologies needed for precision medicine more quickly.
- Rare kidney disease is genetically decoded
- Bartter syndrome type 3 is the result of several structural variants in the genome. By using long-read sequencing, Janine Altmüller and her team from the Max Delbrück Center, the BIH and University Hospital Cologne mapped out the rare disease in unprecedented detail. They have now reported their findings in “Genome Medicine.”
July 2023
- Only long-living RNAs reach their destination
- RNA molecules travel long distances through nerve cells. To reach their destination, they need one thing more than any other – a long life – as a research team led by Marina Chekulaeva from MDC-BIMSB reports in the journal “Molecular Cell.”
- T cells require healthy “power plants”
- Some T cells of the immune system are especially sensitive to genetic disturbances within their mitochondrial power plants. Scientists from BIH and Max Delbrück Center have now published their findings in the journal “Nature Genetics”.
- Colon tissue made in the lab
- The intestine has a complex anatomical structure that includes “crypts.” Researchers led by Michael Sigal have now reconstructed these glands. In “Nature Communications”, they describe how the cells communicate with each other and how people with gut disorders could benefit from their findings.
June 2023
- Leif S. Ludwig wins Heinz Maier-Leibnitz Prize
- Biochemist and physician Leif S. Ludwig of the Berlin Institute of Health at Charité (BIH) and the Max Delbrück Center has been named a recipient of the 2023 Heinz Maier-Leibnitz Prize, as the German Research Foundation (DFG) announced on June 27th.
- Studying herpes encephalitis with mini-brains
- The herpes simplex virus-1 can sometimes cause a dangerous brain infection. Combining an anti-inflammatory and an antiviral could help in these cases, report scientists with the Rajewsky and Landthaler labs and the Organoid Platform at the Max Delbrück Center in “Nature Microbiology.”
- New tool uncovers complex genome interactions
- Genome Architecture Mapping captures complex, multi-way interactions in the genome. This is different than the workhorse technique of 3D genomics, which sees mostly two-way contacts, finds a new study by a team led by Ana Pombo from the Max Delbrück Center, published in “Nature Methods”.
- Examining childhood cancer cell by cell
- Neuroblastoma is the third most common malignancy in children. Berlin-based researchers will investigate how they originate and grow in a new Collaborative Research Centre. The project, supported by the German Research Foundation (DFG), has been granted approximately €13.5 million.
May 2023
- Unwinding clues to disease in DNA’s 3D structure
- The Robson lab at the Max Delbrück Center will be studying how the 3D structure of chromatin controls genes during development and in disease. Leveraging novel single cell methods, they will look at muscular dystrophies and retinal disease. Both seem to be linked to mutations that disrupt the function of non-coding DNA.
- Creating something new together
- With its Music Meets Life Sciences series, the Max Delbrück Center aims to build a bridge between art and science as musicians from the Barenboim-Said Akademie meet with biomedical researchers. In late April, Akademie students gave another concert at MDC-BIMSB, this time playing with Michael Barenboim.
Apr 2023
- How skates learned to fly through water
- Genes are not the only drivers of evolution. The iconic fins of skates are caused by changes in the non-coding parts of the genome and its three-dimensional structure, a research team including Darío Lupiáñez at the Max Delbrück Center reports in “Nature”.
- Nasal vaccine to prevent COVID-19 passes first tests
- Since the beginning of the COVID-19 pandemic, researchers have been working on mucosal vaccines that can be administered through the nose. Now, scientists in Berlin have developed a live attenuated vaccine for the nose. In “Nature Microbiology”, they describe the special immune protection it induces.
Mar 2023
- Long awaited by the pharma industry
- It takes great patience and perseverance to turn research findings into new technologies or therapies. The Helmholtz Initiative and Networking Fund gives financial support to “pathfinder projects” that are particularly promising. Researchers at the Max Delbrück Center have now won grants for three projects.
- The key to the right treatment
- Berlin-based research project MSTARS is entering its second round. Matthias Selbach and Fabian Coscia explain how the Max Delbrück Center is contributing, why the collaboration with Charité is so important, and how studying proteins in cells can help identify the best therapy for a patient.
- An element of surprise and serendipity
- The pianist SooJin Anjou and the scientist Nikolaus Rajewsky are both experts in their respective fields. Together, they have created the event series “Spark”: a concert and meet-up for creative people, an exploration to learn from both sides. On March 13th, the series continued at MDC-BIMSB.
Feb 2023
- Cracking the chromatin code
- Chromatin factors are involved in regulating gene expression. If they do not function properly, this can result in neurological impairments. Ana Pombo and Alexander Kukalev are now receiving almost €400,000 from the DFG for a research project that aims to shed more light on how these factors work.
Jan 2023
- AI analysis of cancer mutations may improve therapy
- Combining single-cell data with a self-learning algorithm reveals how structural changes in chromosomes can trigger cancer. This new method could pave the way for personalized cancer treatments, writes a team led by Ashley Sanders in “Nature Biotechnology”.
- Decoding cellular zipcodes
- Researchers suspect that neurodegenerative diseases occur when messenger RNA (mRNA) goes astray in the neuron. With a new method, Marina Chekulaeva is able to identify “zipcodes” that assign a destination to mRNAs. She has now presented her method in the journal Nature Neuroscience.
- Paul Ehrlich Foundation honors Leif S. Ludwig
- Leif S. Ludwig, a researcher at the Max Delbrück Center and the Berlin Institute of Health at Charité (BIH), will receive the Paul Ehrlich and Ludwig Darmstaedter Young Investigator Award 2023 for a new method to analyze the formation of blood cells, as the Scientific Council of the Paul Ehrlich Foundation announced today.
Nov 2022
- What octopus and human brains have in common
- Cephalopods like octopuses, squids and cuttlefish are highly intelligent animals with complex nervous systems. In “Science Advances”, a team led by Nikolaus Rajewsky of the Max Delbrück Center has now shown that their evolution is linked to a dramatic expansion of their microRNA repertoire.
- ERC Starting Grants for Berlin scientists
- They have their sights set on serious diseases: Gabriele G. Schiattarella analyzes mechanisms of heart failure, Simon Haas wants to improve immunotherapies for leukemia and Michael Sigal would like to prevent gastrointestinal diseases. Now, the ERC is awarding the researchers with a Starting Grant.
- Poor delivery service in the brain
- With funding from the Alzheimer’s Association, Melissa Birol hopes to uncover the molecular causes of age-related dementia. Her hypothesis is that a fatal interaction of tau and ApoE proteins prevents neurons from being supplied with sufficient fat, triggering their death.
Oct 2022
- Searching the sewers for viruses
- Algorithms developed at the Max Delbrück Center are able to quickly detect new SARS-CoV-2 variants in wastewater. But that’s not all: the tool, which Altuna Akalin and his colleagues have now presented in “Science of the Total Environment”, can also find other pathogens. →
- Key processes in acute kidney injury revealed
- Peering into single cells reveals new insights into acute kidney injury. Reporting in “Genome Medicine” and “Kidney International”, research teams at BIMSB, Charité and MHH describe novel gene expression patterns that may lead to new therapeutic approaches and strategies for biomarker discovery. →
September 2022
- Heisenberg Program accepts RNA biologist
- Errors in cellular RNA metabolism are dangerous for nerve cells. For her work in this area, Marina Chekulaeva has now been accepted into the DFG Heisenberg program. →
August 2022
- Award for stem cell scientist Simon Haas
- Simon Haas receives the Young Investigator Award 2022 of the German Stem Cell Network (GSCN). Haas leads the research group Systemic Hematology, Stem Cells & Precision Medicine in the joint research focus "Single Cell Approaches for Personalized Medicine" of BIH, Charité and MDC. →
- CRISPR-based rapid tests for heart attacks & cancer
- A CRISPR-based rapid test called CrisprZyme could help general practitioners to diagnose heart attacks and distinguish between different types of prostate cancer. They do not even need a lab, as an international team of scientists – including Michael Kaminski – reports in "Nature Nanotechnology". →
July 2022
- In-depth profiling of single cells
- Single-cell analyses provide a wealth of molecular and genetic information. A team led by MDC researcher Uwe Ohler is using machine learning to combine these data and produce meaningful profiles of the cells. The Chan Zuckerberg Initiative is now funding the project. →
- How the zebrafish repairs a broken heart
- An MDC research team led by Jan Philipp Junker and Daniela Panáková has found that zebrafish can regenerate heart tissue after injury. Connective tissue cells play an important role in the process by temporarily entering an activated state, as the team reports in “Nature Genetics”. →
- Influential barriers
- The way the genome is folded regulates gene activation, so it can’t be left to chance. Molecular boundaries across the genome keep things in order. A team led by MDC researcher Darío Lupiáñez has discovered how these boundaries work. Their findings, published in Nature Genetics, could help us to better understand developmental diseases or cancer. →
June 2022
- Honing young talent for single-cell medicine
- This spring, the MDC, BIH and Charité hosted the first e:Med Summer School on single-cell- based systems medicine, with the goal of ensuring that basic findings in the field are translated into clinical practice. The event welcomed 20 young biomedical researchers, data scientists and clinicians from around the world. →
- AI identifies cancer cells
- How do cancer cells differ from healthy cells? A new machine learning algorithm called “ikarus” knows the answer, reports a team led by MDC bioinformatician Altuna Akalin in the journal "Genome Biology". The AI program has found a gene signature characteristic of tumors. →
May 2022
- How blood stem cells stay intact for a lifetime
- Stem cells in the bone marrow form the cells of the blood throughout life. In the process, mistakes can occur leading to cancer. Together with a research team from Berlin, Heidelberg and Boston, Simon Haas describes in "Cell Stem Cell" a mechanism that allows the body to protect itself from this risk. →
April 2022
- The RNA profiler
- In order to put their genetic blueprints into action, human cells need RNA-binding proteins. Markus Landthaler observes these proteins while they interact with RNA – in order to understand how they work, and how to make use of them. →
- COVID-19 therapy: Better in combination than alone
- More and more drugs are available for the treatment of COVID-19. Researchers from Charité, FU and MDC in Berlin have investigated the mechanisms of action of antiviral and anti-inflammatory substances. In the journal "Molecular Therapy" they describe that a combination of both works best. →
- Pioneers with broad horizons: Data scientists at HEIBRiDS
- Demand is high for young scientists who are well versed in the data sciences as well as in another discipline. At the Helmholtz graduate school HEIBRiDS in the Berlin-Brandenburg region, eleven institutions have teamed up to train scientists. The range of subjects they cover spans everything from genetic research to astronomy. →
March 2022
- Two ERC Consolidator Grants go to MDC researchers
- How can a heart heal itself? And what determines the sex of a living organism? The European Research Council (ERC) has awarded Consolidator Grants to Dr. Jan Philipp Junker and Dr. Darío Lupiáñez to tackle these questions. Each researcher will receive €2 million over five years for their research. →
- An ornamental fish with superpowers
- Zebrafish have played an important role in basic biomedical research for over 50 years, including research into the causes of congenital heart defects and the consequences of heart attacks. For researchers working with these fish, it's important to respect animal welfare and find ways of improving it. →
- How SARS-CoV-2 takes over the cell's protein factory
- The question of how the Covid virus takes over host cells and suppresses the body's defences has been the subject of much debate. Now a research team led by Marina Chekulaeva at the MDC has pinpointed the crucial mechanism involved. Their results have been published in the journal “RNA”. →
- The fly atlas
- In the Fly Cell Atlas, a project initiated by a team of scientists including Robert Zinzen, researchers are mapping in detail the cells of the fly Drosophila. They have now presented a comprehensive single-cell atlas of the animal, consisting of more than 250 cell types, in the journal Science. →
February 2022
- Watching aggressive breast cancer as it grows
- EMBO fellow Ilan Theurillat investigates how the most lethal subtype of breast cancer develops. He is driven by many unanswered questions such as: Why do fibroblasts wrap themselves around the triple negative tumor like a shield? Can such a tumor form from a single cancer cell? →
- New subtype of Omicron on the rise
- Similar to the recent situation in Denmark, a new subvariant of Omicron known as BA.2 is now spreading in Berlin. This was revealed by an analysis of wastewater samples at the MDC in cooperation with the Berliner Wasserbetriebe and the Berlin lab of the amedes Group. The rapid emergence of BA.2 could prolong the current wave of COVID-19 infection. →
- Genomic regulatory map of the zebrafish
- The zebrafish is an important model organism for studying things like genetic diseases. A regulatory map of its genome has been successfully created using high-throughput experiments and AI methods, a team led by Uwe Ohler now reports in "Cell Genomics" and "Nature Machine Intelligence". →
January 2022
- Open Positions
- for Independent Junior Group Leader (f/m/d) at BIMSB →
more info HERE!
- ERC awards for Dr. Stefanie Grosswendt
- Both researchers study communication, but at different levels: Dr. Stefanie Grosswendt and Dr. Alison Barker have been awarded European Research Council (ERC) Starting Grants. The prestigious grants provide about €1.5 million in funding over a period of five years. →